نتایج جستجو برای: samarium 153

تعداد نتایج: 12920  

Journal: :Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2003
Rong Fu Wang Chun Li Zhang Shou Li Zhu Mei Zhu

OBJECTIVE To assess the therapeutic efficacy and toxicity of samarium-153-ethylenediaminetetramethylene phosphonic acid ((153)Sm-EDTMP) and pamidronate disodium in patients with painful metastatic bone cancer. SUBJECTS AND METHODS Eighteen patients with histopathologically confirmed malignancy and multifocal bone metastases were randomized into two equal groups of 9 patients each. Group A was...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002
Christine Franzius Andreas Schuck Stefan S Bielack

PURPOSE Samarium-153 ethylene diamine tetramethylene phosphonate ((153)Sm-EDTMP), a bone-seeking radiopharmaceutical, provides therapeutic irradiation to osteoblastic bone metastases. Because the dose-limiting toxicity of (153)Sm-EDTMP is thrombocytopenia, a dose-escalation trial using peripheral-blood progenitor cells (PBPCs) or marrow support was conducted to treat metastatic bone cancer. P...

2016
Christopher R. Heery Ravi A. Madan Mark N. Stein Walter M. Stadler Robert S. Di Paola Myrna Rauckhorst Seth M. Steinberg Jennifer L. Marté Clara C. Chen Italia Grenga Renee N. Donahue Caroline Jochems William L. Dahut Jeffrey Schlom James L. Gulley

PSA-TRICOM is a therapeutic vaccine in late stage clinical testing in metastatic castration-resistant prostate cancer (mCRPC). Samarium-153-ethylene diamine tetramethylene phosphonate (Sm-153-EDTMP; Quadramet®), a radiopharmaceutical, binds osteoblastic bone lesions and emits beta particles causing local tumor cell destruction. Preclinically, Sm-153-EDTMP alters tumor cell phenotype facilitatin...

Journal: :The journal of supportive oncology 2011
Fabio M Paes Vinicius Ernani Peter Hosein Aldo N Serafini

Bone pain due to skeletal metastases constitutes the most common type of cancer-related pain. The management of bone pain remains challenging and is not standardized. In patients with multifocal osteoblastic metastases, systemic radiopharmaceuticals should be the preferred adjunctive therapy for pain palliation. The lack of general knowledge about radiopharmaceuticals, their clinical utility an...

Journal: :Clinical nuclear medicine 2006
Robert E Henkin John D Del Rowe Perry W Grigsby Alan C Hartford Hossein Jadvar Roger M Macklis J Anthony Parker Jeffrey Y C Wong Seth A Rosenthal

This guideline is intended to guide appropriately trained and licensed physicians performing therapy with unsealed radiopharmaceutical sources. Adherence to this guideline should help to maximize the efficacious use of these procedures, maintain safe conditions, and ensure compliance with applicable regulations. The topics dealt with in this guideline include indications for the use of iodine-1...

Ali Ghanbarzadeh Amir Hakimi, Amir Reza Jalilian, Hamed Rezaee Jam

Introduction Compartmental analysis allows the mathematical separation of tissues and organs to determine activity concentration in each point of interest. Biodistribution studies on humans are costly and complicated, whereas such assessments can be easily performed on rodents. In this study, we aimed to develop a pharmacokinetic model of 153Sm-maltolate complex as a novel therapeutic agent and...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2008
Mala Chakraborty Elizabeth K Wansley Jorge A Carrasquillo Sarah Yu Chang H Paik Kevin Camphausen Michael D Becker William F Goeckeler Jeffrey Schlom James W Hodge

PURPOSE Exposing human tumor cells to sublethal doses of external beam radiation up-regulates expression of tumor antigen and accessory molecules, rendering tumor cells more susceptible to killing by antigen-specific CTLs. This study explored the possibility that exposure to palliative doses of a radiopharmaceutical agent could alter the phenotype of tumor cells to render them more susceptible ...

Journal: :Biomaterials 2014
Ying Liu Yun Sun Cong Cao Yang Yang Yongquan Wu Dianwen Ju Fuyou Li

Although nanoscale hydroxyapatite [Ca10(PO4)6(OH)2; HA] has been widely investigated as a carrier in the delivery of drugs, genes, or siRNA, the in vivo toxicity of nanoscale HA is not clear and the long-term dynamic distribution in vivo has not hitherto been visualized. In this work, gadolinium-doped HA nanorods (HA:Gd) with an r1 value of 5.49 s(-1) (mm)(-1) have been prepared by a hydrotherm...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید